Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)

SHA:600161 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	5,653	6,168	6,032	5,180	4,261	4,112
Revenue Growth	-10.28%	2.26%	16.43%	21.57%	3.63%	19.35%
Gross Profit Gross Profit Growth	2,199	2,677	3,287	2,628	2,089	1,954
Operating Income Operating Income Growth	1,262	1,781	2,472	1,706	1,293	1,174
Net Income Net Income Growth	757.19	1,091	1,549	1,110	880.92	760.01
Earnings Per Share EPS Growth	0.38	0.55	0.78	0.56	0.44	0.39
EPS Growth	-47.93%	-29.49%	39.29%	26.78%	12.77%	10.73%

Revenue by Geography

Chart

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
China China Growth	6,148
Overseas Overseas Growth	1.62
Total Total Growth	6,150

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	2,168	1,991	2,686	4,555	3,713	4,330
Total Debt Total Debt Growth	152.21	160.82	53.82	42.37	403.17	508.92
Net Cash (Debt) Net Cash Growth	2,016	1,830	2,632	4,513	3,310	3,821
Net Cash Growth	12.32%	-30.46%	-41.68%	36.34%	-13.38%	303.40%
Net Cash Per Share Net Cash Per Share Growth	1.01	0.92	1.33	2.28	1.66	1.97

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	830.01	338.75	819.78	2,394	1,126	980.35
Capital Expenditures CapEx Growth	-621.69	-605.53	-1,067	-1,078	-1,354	-1,132
Free Cash Flow Free Cash Flow Growth	208.31	-266.78	-247.63	1,316	-228.02	-151.35
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	38.91%	43.41%	54.49%	50.72%	49.02%	47.51%
Operating Margin	22.33%	28.87%	40.98%	32.93%	30.34%	28.55%
Pretax Margin	23.09%	29.55%	42.23%	34.72%	33.47%	30.18%
Profit Margin	13.39%	17.69%	25.68%	21.43%	20.67%	18.48%
FCF Margin	3.69%	-4.32%	-4.11%	25.40%	-5.35%	-3.68%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.200	0.200	0.100	0.125	0.042	0.069
Dividend Per Share Growth	-80.00%	100.00%	-20.00%	199.76%	-39.91%	0%
Dividend Yield	1.64%	1.23%	0.50%	0.50%	0.22%	0.36%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	31.80	29.62	26.17	45.94	44.39	52.33
Forward PE	32.84	19.57	29.48	39.63	39.14	45.04
P/FCF Ratio	114.76	-	-	38.74	-	-
PS Ratio	4.23	5.24	6.72	9.84	9.18	9.67

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error